Japan health panel holds off recommending emergency approval of Shionogi COVID-19 pill

Japan health panel holds off recommending emergency approval of Shionogi COVID-19 pill
Representative image Image Credit: Flickr
  • Country:
  • Japan

A panel of Japan's health ministry delayed emergency approval on Wednesday for a highly anticipated oral treatment against COVID-19 that has been developed by Shionogi & Co Ltd.

Health experts on the panel voted to support a motion that more discussions were needed on the effectiveness of the drug.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.